In a time of increasingly individualized healthcare, Elizabeth Philp has become a formidable figure of innovation, particularly in the fast-evolving field of compounded pharmacy. As the co-founder and CEO of Roseway Labs, Philp is at the vanguard of a drive to make tailor-made medications more available, questioning the standard one-size-fits-all